Dr Chiara Braconi speaks to ecancer about genomic testing in biliary tract cancers. She initially talks about the three subtypes of cholangiocarcinoma and gallbladder cancer.
Dr Braconi then expands on why, when, and how to test BTC patients.
She talks about the limitations of clinical application in BTC and future considerations.
Dr Braconi also compares single-gene analysis to multi-gene analysis. She concludes by talking about liquid biopsies for BTC.